External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome

European Urology

Volumn 58, Issue 5, 2010, Pages 727-732

  Auprich, Marco ^b   Haese, Alexander ^a   Walz, Jochen ^c   Pummer, Karl ^b   De La Taille, Alexandre ^d   Graefen, Markus ^a   De Reijke, Theo ^e   Fisch, Margit ^a   Kil, Paul ^f   Gontero, Paolo ^g   Irani, Jacques ^h   Chun, Felix K H ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c INSTITUT PAOLI CALMETTES   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f CPRLab   (Netherlands)

^g UNIVERSITY OF TURIN   (Italy)

^h POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Biomarker; External validation; Nomogram; Prostate biopsy; Prostate cancer; Prostate cancer gene 3

Indexed keywords

PROSTATE CANCER ANTIGEN 3; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALIBRATION; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HISTOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOMES RESEARCH; PATIENT REFERRAL; PRECANCER; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; VALIDATION STUDY;

ANTIGENS, NEOPLASM; BIOPSY; HUMANS; MALE; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957575094     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.06.038     Document Type: Article

References (18)

1. W.J. Catalona, A.W. Partin, and K.M. Slawin Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial JAMA 279 1998 1542 1547
2. M.J. Bussemakers, A. van Bokhoven, and G.W. Verhaegh DD3: a new prostate-specific gene, highly overexpressed in prostate cancer Cancer Res 59 1999 5975 5979
3. D. Hessels, J.M.T. Klein Gunnewiek, and I. van Oort DD3 PCA3-based molecular urine analysis for the diagnosis of prostate cancer Eur Urol 44 2003 8 16 discussion 15-6
4. J. Groskopf, S.M. Aubin, and I.L. Deras APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer Clin Chem 52 2006 1089 1095
5. A. Haese, A. de la Taille, and H. van Poppel Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy Eur Urol 54 2008 1081 1088
6. L.S. Marks, Y. Fradet, and I.L. Deras PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy Urology 69 2007 532 535
7. I.L. Deras, S.M. Aubin, and A. Blase PCA3: a molecular urine assay for predicting prostate biopsy outcome J Urol 179 2008 1587 1592
8. H. Nakanishi, J. Groskopf, and H.A. Fritsche PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance J Urol 179 2008 1804 1809 discussion 1809-10
9. E.J. Whitman, J. Groskopf, and A. Ali PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume J Urol 180 2008 1975 1978 discussion 1978-9
10. F.K. Chun, A. de la Taille, and H. van Poppel Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram Eur Urol 56 2009 659 668
11. M.W. Kattan Judging new markers by their ability to improve predictive accuracy J Natl Cancer Inst 95 2003 634 635
12. M.W. Kattan Evaluating a new marker's predictive contribution Clin Cancer Res 10 2004 822 824
13. L.A. Eskew, R.L. Bare, and D.L. McCullough Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate J Urol 157 1997 199 202 discussion 202-3
14. M. Amin, L. Boccon-Gibod, and L. Egevad Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens Scand J Urol Nephrol Suppl 216 2005 20 33
15. M.P. Van Gils, E.B. Cornel, and D. Hessels Molecular PCA3 diagnostics on prostatic fluid Prostate 67 2007 881 887
16. E.W. Steyerberg, F.E. Harrell Jr., G.J. Borsboom, M.J. Eijkemans, Y. Vergouwe, and J.D. Habbema Internal validation of predictive models: efficiency of some procedures for logistic regression analysis J Clin Epidemiol 54 2001 774 781
17. T. Steuber, M. Graefen, and A. Haese Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy J Urol 175 2006 939 944 discussion 944
18. F.K. Chun, A. Briganti, and M. Graefen Development and external validation of an extended repeat biopsy nomogram J Urol 177 2007 510 515 (Pubitemid 46054043)